Time since we first saw it
Day 2
Similar jobs usually come down between day 1 and day 15.
From 1,368 similar postings that came down. Coming down is not always a hire.
San Francisco, CA · San Francisco, California, United States
Actively hiring, first seen by us 2 days agoLocation type: On-siteFrom the employer’s posting
Employment type: Full-timeFrom the employer’s posting
Department: AIFrom the employer’s posting
Operate across the entire AI stack: evals, agentic harnesses, and models
Build AI that learns from real human biology rather than the literature
Help build the model that orchestrates the robotic lab's experiments
Must be able to operate across the entire AI stack: evals, agentic harnesses, and models
For engineers, it means building AI that learns from real human biology instead of the literature.
and the model that orchestrates it all
Will you now or in the future require sponsorship for employment visa status (e.g., H-1B visa status)?From the employer’s application form
Must be able to operate across the entire AI stack: evals, agentic harnesses, and models
Actively hiringFirst seen by us 2 days ago, still listed, and not a repost of an earlier posting.
These dates show when we found the posting. Check the employer’s website to confirm it is still accepting applications.
Day 2
Similar jobs usually come down between day 1 and day 15.
From 1,368 similar postings that came down. Coming down is not always a hire.
3 open jobs
Open jobs by the week we first saw them, last 12 weeks.
Hiring recordCheck the employer’s posting for the current role and application details.
Already applied? Track this application
More than 95% of drugs that pass animal testing fail in human trials. A single new drug takes about $2.6 billion and 12.5 years to develop, and most of that effort goes to candidates that were never going to work in people.
AI was supposed to change this. But most AI for drug discovery is still trained on the same inputs that got us here: animal data, irreproducible papers, and cell lines that don’t respond like living tissue. A model can only learn the biology it’s shown, and no amount of scale or compute fixes bad data.
What’s missing is data on how living human tissue responds to a drug, across the range of people who will actually take it. That data barely exists, because there has been no way to generate it at scale without putting patients at risk.
Parallel Bio grows it. Our expert biologists build living human immune systems, called immune organoids, from a proprietary biobank spanning ages, sexes, ancestries and disease states. That means we can ask how a drug behaves in an older patient, a specific ancestry or an autoimmune background, not just in an average donor. We've already modeled immunotoxicology, immunogen stimulation and two autoimmune diseases, with more on the way. Our founders are world experts in scalable organoids. Robert is a Stanford-trained immunologist. Juliana trained in the lab that invented the first organoid and later automated them at System1 Biosciences.
We run these experiments in an AI-driven robotic lab, and every experiment makes our world model smarter, which in turn chooses better experiments. We build every layer ourselves: the biology, the robotics, the data infrastructure, and the model that orchestrates it all. The whole lab is callable over API and MCP, so AI agents can design and run real biological experiments, within safety limits we set. For biologists, that means asking questions at a scale and pace no bench can match. For engineers, it means building AI that learns from real human biology instead of the literature.
It's already working. Our platform is 87% concordant with clinical outcomes, compared with roughly 3% translational success for animal models. Five Fortune 500 companies use it to test drugs, and our data has informed a Phase 1 trial. We've raised ~$30M from AIX Ventures, Marc Benioff, Jeff Dean and Y Combinator. With the FDA Modernization Act 3.0 and the FDA's March 2026 validation framework, regulation is moving our way.
The opportunity is generational. We're building the first scaled engine for real human biological data, and using it to know which drugs will work in people before they ever reach a trial.
Must be able to operate across the entire AI stack: evals, agentic harnesses, and models
Parallel Bio is an equal opportunity employer committed to fostering an inclusive and respectful workplace. We encourage applications from individuals of all backgrounds, regardless of age, gender, ethnicity, religion, disability, or sexual orientation.
New AI Engineer postings at the employers we follow are up 340% over the last 6 weeks compared with the 6 before.
Each bar is one week of new postings. The darkest bars are the last 6 weeks.
Counted from the hiring pages we’ve followed for at least five weeks, so employers we add don’t look like growth. Updated weekly.
We file this job under AI Engineer, by the work the posting describes.
AI engineers build products on top of AI models that already exist, most often large language models: they connect a model to a company's data and tools and ship the assistants, agents and search features people use.
Postings ask for strong Python or TypeScript, experience with model APIs, retrieval and agent frameworks, and ways to test whether the model's answers are good enough.
An ML engineer trains and serves models; an AI engineer usually starts from a model someone else trained and builds the product around it, though titles often mix the two.
Selected passages from the saved posting. Check the full description for conditions and exceptions.
No pay amount identified in the saved description.
San Francisco, California, United States
Working pattern and location restrictions need checking in the full posting.
No clear work-authorization passage found. Eligibility is unconfirmed.
We couldn’t identify enough role detail in this saved description to support an AI answer. Read the full posting